Status:
COMPLETED
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
Lead Sponsor:
Institute of Health Information and Statistics of the Czech Republic
Collaborating Sponsors:
Ministry of Health, Czech Republic
Masaryk University
Conditions:
COVID
SARS-CoV-2
Eligibility:
All Genders
8+ years
Brief Summary
The aim of the SARS-CoV-2-CZ-Immunity study is to determine the time profile of the presence of antibodies against SARS-CoV-2 in blood plasma by quantification of antibodies or performing a rapid test...
Detailed Description
COVID-19 is caused by a new type of coronavirus called SARS-CoV-2. It is a highly infectious disease, manifested mainly by fever, respiratory problems, muscle pain, and fatigue. However, despite the p...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- signed Informed Consent
- residing in Prague, Central Bohemian Region or South Moravian Region
- demographic criteria: persons aged 8-17 and persons aged 18 and more
- clinical criteria: (i) diagnosis of COVID-19 confirmed by PCR (ii) cured patients: clearance of SARS-CoV-2 viral RNA demonstrated by two consecutive negative RT-PCR results (iii) without acute health problems
Exclusion
Key Trial Info
Start Date :
May 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2020
Estimated Enrollment :
695 Patients enrolled
Trial Details
Trial ID
NCT04453280
Start Date
May 18 2020
End Date
June 3 2020
Last Update
July 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Health Information and Statistics of the Czech Republic
Prague, Czechia, 128 01